This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionLast revisionBoth sides next revision | ||
home:pathogenesis:vitamind:low25d [09.16.2016] – [Anomalies] sallieq | home:pathogenesis:vitamind:low25d [01.31.2019] – [Diseases associated with low levels of 25-D] sallieq | ||
---|---|---|---|
Line 59: | Line 59: | ||
* myocardial infarction (heart attack) (({{pubmed> | * myocardial infarction (heart attack) (({{pubmed> | ||
* obesity (({{pubmed> | * obesity (({{pubmed> | ||
- | * osteoarthritis (({{pubmed> | + | * osteoarthritis (({{pubmed> |
* osteoporosis and osteopenia (({{pubmed> | * osteoporosis and osteopenia (({{pubmed> | ||
* pain (myalgia) (({{pubmed> | * pain (myalgia) (({{pubmed> | ||
Line 86: | Line 86: | ||
* **atherosclerosis in African Americans** – Vitamin D is widely used to treat patients with osteoporosis and/or low vitamin D levels based on a medically accepted normal range. This " | * **atherosclerosis in African Americans** – Vitamin D is widely used to treat patients with osteoporosis and/or low vitamin D levels based on a medically accepted normal range. This " | ||
+ | |||
+ | {{tag> | ||
===== Notes and comments ===== | ===== Notes and comments ===== |